[ANCA associated vasculitis and PRGN].
Arimura
Yoshihiro
Y
Kawashima
Souko
S
Yoshihara
Ken
K
D000818:Animals; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000502:physiology; D015415:Biomarkers / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D005921:Glomerulonephritis; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012008:Recurrence; D012263:Ribonucleosides / Q000627:therapeutic use; D014657:Vasculitis / Q000145:classification / Q000175:diagnosis / Q000209:etiology
D019268:Antibodies, Antineutrophil Cytoplasmic; D015415:Biomarkers; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D003520:Cyclophosphamide; D009173:Mycophenolic Acid